• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma.

作者信息

Lin Peng, Yang Hong

机构信息

Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

J Hepatol. 2022 Sep;77(3):879-880. doi: 10.1016/j.jhep.2022.03.008. Epub 2022 Mar 28.

DOI:10.1016/j.jhep.2022.03.008
PMID:35358615
Abstract
摘要

相似文献

1
EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma.EFNA3是肝细胞癌患者总生存期的一个预后生物标志物。
J Hepatol. 2022 Sep;77(3):879-880. doi: 10.1016/j.jhep.2022.03.008. Epub 2022 Mar 28.
2
Reply to: 'EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma'.回复：“EFNA3是肝细胞癌患者总生存期的预后生物标志物”
J Hepatol. 2022 Sep;77(3):880-882. doi: 10.1016/j.jhep.2022.05.004. Epub 2022 May 20.
3
dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.dbPHCC：一个用于肝细胞癌预后生物标志物的数据库，提供在线预后建模。
Biochim Biophys Acta. 2016 Nov;1860(11 Pt B):2688-95. doi: 10.1016/j.bbagen.2016.02.017. Epub 2016 Mar 2.
4
Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.β1,6-N-乙酰氨基葡萄糖转移酶V表达在肝细胞癌患者中的预后意义
Jpn J Clin Oncol. 2015 Sep;45(9):844-53. doi: 10.1093/jjco/hyv080. Epub 2015 Jun 7.
5
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.用于预测肝细胞癌患者生存的潜在预后长链非编码RNA生物标志物的鉴定
Cell Physiol Biochem. 2018;48(5):1854-1869. doi: 10.1159/000492507. Epub 2018 Aug 9.
6
Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection.影响肝硬化肝细胞癌根治性切除术后早期复发的预后标志物。
Int J Biol Markers. 2019 Jun;34(2):123-131. doi: 10.1177/1724600819834306. Epub 2019 Apr 12.
7
Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma.血清外泌体 miR-320a 表达降低是肝细胞癌患者的预后不良因素。
J Int Med Res. 2020 Apr;48(4):300060519896144. doi: 10.1177/0300060519896144.
8
Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?接受免疫治疗的肝细胞癌患者的预后预测：我们做到了吗？
J Hepatol. 2022 Apr;76(4):987-988. doi: 10.1016/j.jhep.2021.11.007. Epub 2021 Nov 13.
9
Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.ZWINT表达降低与肝癌术后患者的不良预后相关。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794190. doi: 10.1177/1533033818794190.
10
Kindlin-2: a novel prognostic biomarker for patients with hepatocellular carcinoma.Kindlin-2：一种用于肝细胞癌患者的新型预后生物标志物。
Pathol Res Pract. 2015 Mar;211(3):198-202. doi: 10.1016/j.prp.2014.09.011. Epub 2014 Oct 2.

引用本文的文献

1
EphA3/EFNA3 Reverse Signalling Promotes Epithelial-to-Mesenchymal Transition via ERK Pathway to Facilitate Colorectal Cancer Metastasis.EphA3/EFNA3反向信号通过ERK途径促进上皮-间质转化以促进结直肠癌转移
Dig Dis Sci. 2025 Sep 10. doi: 10.1007/s10620-025-09386-0.
2
NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated glycolysis.NSUN5通过m5C-EFNA3介导的糖酵解加速肝细胞癌的进展。
BMC Cancer. 2025 Jul 29;25(1):1237. doi: 10.1186/s12885-025-14714-8.
3
Exploring LAT-derived miRNAs as regulatory agents of EphrinA3 in glioblastoma multiforme.
探索源自LAT的微小RNA作为多形性胶质母细胞瘤中EphrinA3的调节因子。
Biochem Biophys Rep. 2025 Jul 6;43:102132. doi: 10.1016/j.bbrep.2025.102132. eCollection 2025 Sep.
4
TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma.跨膜蛋白101（TMEM101）的表达及其对肝细胞癌免疫细胞浸润和预后的影响。
Sci Rep. 2024 Dec 30;14(1):31847. doi: 10.1038/s41598-024-83174-0.
5
GD-Net: An Integrated Multimodal Information Model Based on Deep Learning for Cancer Outcome Prediction and Informative Feature Selection.GD-Net：一种基于深度学习的集成多模态信息模型，用于癌症预后预测和信息性特征选择。
J Cell Mol Med. 2024 Dec;28(23):e70221. doi: 10.1111/jcmm.70221.
6
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway.青蒿琥酯通过抑制 Stat3/Akt 信号通路抑制 EFNA3 从而抑制脉络膜黑色素瘤的发生。
J Cancer Res Clin Oncol. 2024 Apr 17;150(4):202. doi: 10.1007/s00432-024-05711-8.
7
Hub gene identification and molecular subtype construction for in gastric cancer via machine learning methods and NMF algorithm.基于机器学习方法和 NMF 算法的胃癌 枢纽基因识别与分子亚型构建。
Aging (Albany NY). 2023 Sep 26;15(21):11782-11810. doi: 10.18632/aging.205053.